Artal Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-121,182
| Closed | -$9.97M | – | 110 |
|
|
2023
Q2 | $9.97M | Buy |
121,182
+32,550
| +37% | +$2.68M | 0.31% | 48 |
|
|
2023
Q1 | $9.11M | Buy |
88,632
+632
| +0.7% | +$64.9K | 0.54% | 44 |
|
|
2022
Q4 | $12.9M | Hold |
88,000
| – | – | 0.72% | 34 |
|
|
2022
Q3 | $14.9M | Hold |
88,000
| – | – | 0.63% | 34 |
|
|
2022
Q2 | $10.2M | Hold |
88,000
| – | – | 0.54% | 33 |
|
|
2022
Q1 | $8.78M | Buy |
88,000
+40,000
| +83% | +$3.99M | 0.37% | 53 |
|
|
2021
Q4 | $7.46M | Hold |
48,000
| – | – | 0.2% | 76 |
|
|
2021
Q3 | $11.3M | Hold |
48,000
| – | – | 0.25% | 72 |
|
|
2021
Q2 | $16.3M | Hold |
48,000
| – | – | 0.33% | 59 |
|
|
2021
Q1 | $19.4M | Hold |
48,000
| – | – | 0.34% | 58 |
|
|
2020
Q4 | $31.9M | Buy |
48,000
+8,000
| +20% | +$5.32M | 0.69% | 37 |
|
|
2020
Q3 | $18.6M | Buy |
40,000
+8,000
| +25% | +$3.72M | 0.45% | 39 |
|
|
2020
Q2 | $18.7M | Buy |
+32,000
| New | +$18.7M | 0.52% | 37 |
|